CASB618 polynucleotides and polypeptides and their use

Details CASB618 polynucleotides and polypeptides and their use CASB618 polynucleotides and polypeptides and their use

2005-08-09

2008-12-30

Yu, Misook (Department: 1642)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

Reexamination Certificate

active

07470782

ABSTRACT:
CASB618 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB618 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.

REFERENCES:
patent: 5840839 (1998-11-01), Wang et al.
patent: 7105315 (2006-09-01), Lasek et al.
patent: WO95/17210 (1995-06-01), None
patent: WO96/08514 (1996-03-01), None
patent: WO98/32865 (1998-07-01), None
patent: WO99/49030 (1999-09-01), None
patent: WO99/49055 (1999-09-01), None
patent: WO/0061596 (2000-10-01), None
patent: WO/0056891 (2001-09-01), None
EST Accession No. AI304327/c downloaded from http://es/ScoreAccessWeb/GetItem.action?AppId=11199820&seqId3 on Nov. 7, 2007.
Boon, Advances in Cancer Research 58:177-210 (1992).
NCBI Accession No. 1BKN B (Jul. 9, 1998).
Ezzell, J. NIH Res. 7:46-49 (1995).
Gimmi, E. R., et al., Deletions in the SV40 late polyadenylation region downstream of the AATAAA mediate similar effects on expression in various mammalian cell lines,Nucleic Acids(1988)16(18): 8977-8997.
Ugozzoli, et al. “Combinations of protein polysaccharide conjugate vaccine for intranasal immunization.” J. Infect. Dis. 186; 1358-1361 (2002).
Bravo, et al. “The new DTPw-HBV-Hib combination vaccine can be used at the WHO schedule with a monovalent dose of hepatitis B vaccine at birth.” Southeast Asian J. Trop. Med. Public Health 29; 772-778 (1998).
Zepp, et al. “Evidence for induction of polysaccharide specific B-cell memory in the first year of life: plain Haemophilus influenzae type b-PRP (Hib) boosters children primed with a tetanus-conjugate HIb-DTPa-HBV combined vaccine.” J. Pediatr 156; 18-24 (1997).
Richmond, et al. “Safety and immunogenicity of a new Neisseria meningitides serogroup C-tetanus toxoid conjugate vaccine in healthy adults.” Vaccine 18; 641-646 (2000).
Choo, et al. “Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with group A + C meningococcal polysaccharide vaccine in adolescents in a randomized observer-blind controlled trial.” Vaccine 18; 2686-2692 (2000).
MacLennan, et al. “Safety, Immunogenicity and induction of immunologic memory by a serogroup C meningiciccal conjugate vaccine in infants.” JAMA 283: 2795-2801 (2000).
Definition of “Celsius” in Merriam-Webster dictionary downloaded from url www. M-w.com on Jun. 26, 2004.
Ezzell, J NIH Res., (190): 1793-1799 (1995).
Van den Eynde et al., J. Exp. Med. (190):1793-1799 (1999).
Benjamini and Leskowitz, Immunology, A Short Course, Wiley-Liss, (1991) Chapter 3, pp. 37-45 only.
Fernandez, et al. “Randomised trial of the immunogenicity of fractional dose regiments of PRP-THaemophilus influenzaetype B conjugate Vaccine.”Am. J. Trop. Med. Hyg.62; 485-490 (2000).
A.H.F.S. Category 80:12 Haemophilus b. conjugate vaccine (Tetanus toxoid conjugate).
Spitler,Cancer Biotherapy, 1995, 10: 1-3.
Mankovich et al.,Journal of Bacteriology(1989)171:5325-31.
Alberts et al.,Molecular Biology of the Cell, 3rdEd. (1994) 465.
Shantz and Pegg,Int J of Biochem and Cell Biol. (1999) (31): 107-122.
McClean and Hill, Eur J of Cancer (1993 (29A): 2243-2248.
Fu et al., EMBO Journal (196) (15) 4392-4401.
Riott et al., Immunoology, 4thEd. 1996, Mosby pp. 7.8-7.12, and Chapter 10 only.
EMBL Sequence Database, Nov. 23, 1998, Accession No. A1274929.
EMBL Sequence Database, Nov. 24, 1998, Accession No. A1281211.
International Search Report from International Application No. PCT/EP00/02048.

Affiliated with

Also associated with

Rating

CASB618 polynucleotides and polypeptides and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CASB618 polynucleotides and polypeptides and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CASB618 polynucleotides and polypeptides and their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4036533